05 Mar 2022

Steve’s hiking journey

“Hiking, it’s in the blood!”

As an avid hiker, Steve has led walking groups for the last twenty years and climbed the highest peaks in forty countries. However, in February 2021 Steve was diagnosed with chronic lymphocytic leukaemia.

Yet Steve was determined to continue with his passion for hiking.

Since getting the diagnosis during the pandemic, it has changed my life, as it affects everything. The places I go and what I do. I had to change my job and avoid going out into crowded places due to my reduced immunity.

But I was determined that it would not change my love of hiking and the joy it brings me. A year later, I decided to take on the Lyke Wake Walk as a fundraising activity, as I wanted something positive to come out of my diagnosis.

I stepped up my usual walking routine by getting a few 20-mile walks under my belt, which was great as it gave me something to focus on. Something to aim for.

Then the day finally came for me to once again lace up my hiking boots and I was ready for the challenge. The Lyke Wake Walk is a 24 hour challenge, but I completed the 40.5-mile route in 15 hours. When I set off on my hike, I took in the scenery and enjoyed being back out on a hiking trail.

Along the way, I met up with my friend John at the RV points, which was a morale boost as he was always ready with a brew to keep me going. During the final 100 meters, he laced up his boots and joined me and we finished the Lyke Wake Walk together.

My fundraising target was £1,000 but I have now raised over £1,300 for Leukaemia UK, as I hope to continue to raise awareness of blood cancer.

Steve shares his advice for anyone who is considering taking on a challenge, “by helping others, you are ultimately helping yourself both physically and mentally”.

We are so grateful for Steve’s support and look forward to hearing what hike he will take on next.  

Read more of our stories.

Related posts

University of Southampton’s Dr Giorgia Chiodin Wins Olive Boles Innovation Award

7 November 2024

University of Southampton’s Dr Giorgia Chiodin Wins Olive Boles Innovation Award

Dr Giorgia Chiodin from the University of Southampton has been awarded the prestigious Olive Boles Innovation Award for 2024. Awarded annually to a Leukaemia UK John Goldman Fellow, this award…

Leukaemia UK reveals new strategy to go further than ever to stop leukaemia devastating lives

25 May 2022

Leukaemia UK reveals new strategy to go further than ever to stop leukaemia devastating lives

Leukaemia UK has revealed a new strategy to go further than ever to save and improve more lives, through research, awareness and advocacy.

Can the unique differences between stem cells tell us how well CML treatment will work?

22 May 2023

Can the unique differences between stem cells tell us how well CML treatment will work?

What if we could predict how chronic myeloid leukaemia (CML) patients will respond to treatment? Could the unique signatures of CML stem cells hold the key to personalising treatment for…

Leukaemia UK announces innovative projects by four female researchers addressing aggressive blood cancers

23 October 2024

Leukaemia UK announces innovative projects by four female researchers addressing aggressive blood cancers

Leukaemia UK has today announced it will invest £600,000 into four groundbreaking research projects aimed at developing kinder, more effective treatments for various aggressive blood cancers, including acute myeloid leukaemia…